▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3032 by analyst upside · 2026-09-28
ADUS
Addus HomeCare Corporation
Healthcare · Market Cap $2B · P/E 19.9x
ANALYST PRICE TARGET
+18.0%
implied upside to consensus target
Current Price $113.19
Consensus Target $133.54
Bull Target $155.0
Bear Target $96.0
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
7
Hold
2
Sell
1
52-Week Low $87.95
52-Week High $124.44
YTD Return +6.2%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 19.9x
Forward P/E 15.1x
EPS (TTM) $5.70
PEG Ratio 0.99
Dividend Yield N/A
Revenue (TTM) $1.5B
Profit Margin 7.1%
52-WEEK RANGE
52-Week Low $87.95
52-Week High $124.44
Current Price $113.19
Bear Target $96.0
Bull Target $155.0
● Now $113.19 ● Target $133.54
TRADING DATA
Avg Volume 225K
YTD Return +6.2%
Analyst Count 13
Consensus Buy
Upside to Target +18.0%
Last Updated 2026-09-28

ANALYST SUMMARY

Addus HomeCare Corporation (ADUS) is currently trading at $113.19 with a Wall Street consensus price target of $133.54, implying potential upside of 18.0% over the next 12 months. 13 analysts currently cover ADUS, with a consensus rating of Buy - 77% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $155.0, while the most cautious has a target of $96.0.

ADUS operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 6.2% year-to-date and is currently trading near the upper end of its 52-week range of $87.95 – $124.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PBH +45.5%
Prestige Consumer Healthcare Inc.
$2B · P/E 13.1x · Buy
TMDX +14.1%
TransMedics Group, Inc.
$3B · P/E 22.1x · Buy
MD +0.1%
Pediatrix Medical Group, Inc.
$2B · P/E 12.6x · Hold
OMER +37.0%
Omeros Corporation
$1B · P/E 12.2x · Buy
HCSG +28.3%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ADUS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B of A Securities ↓ Downgrade
Buy → Neutral 2026-09-14 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-08-05 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-07-09 Building track record
Citizens reit
Market Outperform → Market Outperform 2026-05-18 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-05-15 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-05-06 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-03-25 Building track record
Stephens & Co. - Reiterated
Overweight → Overweight 2026-02-25 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
54
out of 100
Coverage depth
20/30
Consensus clarity
20/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →